Emmessar Biotech and Nutrition Ltd (EMME)

Currency in INR
27.94
-0.97(-3.36%)
Closed·

EMME Financial Summary

Key Ratios

P/E Ratio54.39
Price/Book1.85
Debt / Equity1.48%
Return on Equity4.18%
Dividend Yield0.00%
EBITDA10.56M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
31/03
2017
31/03
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
2025
31/03
* In Millions of INR (except for per share items)

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
-0.16 / --
Revenue / Forecast
7.04M / --
EPS Revisions
Last 90 days

FAQ

What were Emmessar Biotech and Nutrition's earnings for the latest quarter?

The Emmessar Biotech and Nutrition EPS (TTM) is 0.61. Emmessar Biotech and Nutrition reported sales of 7.04, net income of -0.69, and EPS of -0.16 for the latest quarter.

What was Emmessar Biotech and Nutrition's net income for the latest quarter?

Emmessar Biotech and Nutrition's net income for the latest quarter was -0.69.

How did Emmessar Biotech and Nutrition's performance compare year-over-year in the latest quarter?

The company's revenue moved from 5.30 in the previous quarter to 7.04 in the latest quarter, and net income moved from 0.17 to -0.69 compared to the previous quarter.

What is Emmessar Biotech and Nutrition's net profit margin on a TTM basis?

Emmessar Biotech and Nutrition's trailing twelve months (TTM) net profit margin is 12.07%.

How does Emmessar Biotech and Nutrition's debt to equity ratio compare to industry standards?

Emmessar Biotech and Nutrition's total debt-to-equity ratio is 1.48%.

What is Emmessar Biotech and Nutrition's return on investment on a TTM basis?

Emmessar Biotech and Nutrition's trailing twelve months (TTM) return on investment (ROI) is 4.18%.

What were Emmessar Biotech and Nutrition's total assets and liabilities in the latest quarter?

As of the latest quarter, Emmessar Biotech and Nutrition reported total assets of 92.20 million and total liabilities of 4.73 million.

How has Emmessar Biotech and Nutrition's total revenue grown this year?

Emmessar Biotech and Nutrition's total revenue was 5.30 in the previous quarter and 7.04 in the latest quarter.

What is Emmessar Biotech and Nutrition's gross margin on a TTM basis?

Emmessar Biotech and Nutrition's trailing twelve months (TTM) gross margin is 93.06%.

What was Emmessar Biotech and Nutrition's revenue per share for the latest quarter?

Emmessar Biotech and Nutrition's revenue per share for the latest quarter was 299.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.